Mark Chen

Mark Chen

Director/Board Member at GLOBAL CORD BLOOD CORPORATION
58 year
Finance
Consumer Services
Health Services

Profile

Mr. Mark D.
Chen is an Independent Non-Executive Director at MEGAIN Holding (Cayman) Co. Ltd., an Independent Non-Executive Director at Global Cord Blood Corp.
and a Managing Partner at Pantheon Pacific Capital Management Ltd. He is on the Board of Directors at MEGAIN Holding (Cayman) Co. Ltd. and Global Cord Blood Corp.
Mr. Chen was previously employed as an Independent Director by Skystar Bio-Pharmaceutical Co., a Chairman, President & Chief Executive Officer by Pantheon China Acquisition Corp., a Managing Director by Ecc Advisors LLC, a Managing Director by Easton Capital Investment Group, and a Senior Executive Officer by Suredata, Inc. He also served on the board at Sonics, Inc. He received his undergraduate degree from Shanghai Jiao Tong University, a graduate degree from The Pennsylvania State University and an MBA from Columbia Business School.

Mark Chen active positions

CompaniesPositionStart
GLOBAL CORD BLOOD CORPORATION Director/Board Member 01/01/2009
MEGAIN HOLDING (CAYMAN) CO., LTD. Director/Board Member 01/02/2021
Corporate Officer/Principal 01/01/2009

Former positions of Mark Chen

CompaniesPositionEnd
Chief Executive Officer 05/08/2009
Private Equity Investor 12/03/2006
Chief Executive Officer 01/01/2006
Suredata, Inc.
Founder -
SKYSTAR BIO-PHARMACEUTICAL COMPANY Director/Board Member -
See the detail of Mark Chen's experience

Education of Mark Chen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

81

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Finance

Health Services

Consumer Services

Technology Services

Finance

Health Technology

Consumer Services

Suredata, Inc.

Consumer Services

Finance

Finance

Electronic Technology